Production (Stage)
Allarity Therapeutics, Inc.
ALLR
$1.03
-$0.035-3.29%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -23.40M | -24.52M | -18.78M | -11.64M | -12.39M |
| Total Depreciation and Amortization | 18.00K | 9.00K | 17.00K | 21.00K | 29.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.81M | 7.18M | 3.40M | -5.02M | -4.25M |
| Change in Net Operating Assets | -2.97M | 62.00K | -366.00K | 974.00K | 5.67M |
| Cash from Operations | -18.55M | -17.26M | -15.73M | -15.66M | -10.94M |
| Capital Expenditure | -298.00K | -298.00K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -298.00K | -298.00K | -- | -- | -- |
| Total Debt Issued | 0.00 | 1.34M | 1.34M | 1.34M | 2.39M |
| Total Debt Repaid | -1.34M | -1.34M | -1.34M | -1.69M | -3.70M |
| Issuance of Common Stock | 48.46M | 37.35M | 33.64M | 40.01M | 19.18M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 2.94M | 2.94M | 2.94M | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -3.50M | -3.50M | -3.50M | -5.00M | -6.65M |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 46.56M | 36.79M | 33.08M | 34.66M | 11.22M |
| Foreign Exchange rate Adjustments | -314.00K | 137.00K | -285.00K | -185.00K | -257.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 27.39M | 19.37M | 17.06M | 18.81M | 17.00K |